Adial Pharmaceuticals (ADIL) EPS (Basic) (2017 - 2026)
Adial Pharmaceuticals (ADIL) posted EPS (Basic) of -$1.43 for Q1 2026, up 78.22% sequentially from -$6.55 in Q3 2025, and up 83.99% YoY from -$0.78 in Q1 2025.
Adial Pharmaceuticals (ADIL) EPS (Basic) (2017 - 2026) Analysis & Trends
Adial Pharmaceuticals has reported EPS (Basic) for 10 years, with the latest figure at -$1.43 in Q1 2026.
- Quarterly EPS (Basic) rose 83.99% year-over-year to -$1.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.71 (up 88.38% YoY) and the FY2025 annual result came in at -$36.49, up 46.35% from the prior year.
- EPS (Basic) climbed to -$1.43 in Q1 2026 per ADIL's latest filing, from -$6.55 in the prior quarter.
- Over five years, EPS (Basic) peaked at $4.86 in Q2 2023 and troughed at -$78.5 in Q1 2022.
- A 5-year average of -$26.2 and a median of -$11.8 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) jumped 130.94% in 2023, then sank 5928.14% in 2024.
- Over 5 years, EPS (Basic) stood at -$63.65 in 2022, then jumped by 99.56% to -$0.28 in 2023, then sank by 2566.26% to -$7.44 in 2024, then increased by 11.96% to -$6.55 in 2025, then jumped by 78.22% to -$1.43 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.43, -$6.55, and -$6.59 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Adial Pharmaceuticals | 26.99 Mn | 26.99 Mn | - | -11.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.43 |
| Sep 30, 2025 | -6.55 |
| Jun 30, 2025 | -6.59 |
| Mar 31, 2025 | -8.91 |
| Dec 31, 2024 | -7.44 |
| Sep 30, 2024 | -47.67 |
| Jun 30, 2024 | -14.69 |
| Mar 31, 2024 | -54.81 |
| Dec 31, 2023 | -0.28 |
| Sep 30, 2023 | -0.79 |
| Jun 30, 2023 | 4.86 |
| Mar 31, 2023 | -68.63 |
| Dec 31, 2022 | -63.65 |
| Sep 30, 2022 | -48.42 |
| Jun 30, 2022 | -15.70 |
| Mar 31, 2022 | -78.50 |
| Dec 31, 2021 | -199.21 |
| Sep 30, 2021 | -135.96 |
| Jun 30, 2021 | -157.80 |
| Mar 31, 2021 | -189.86 |